Warfarin pharmacogenetics: Economic considerations.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

StandardStandard

Warfarin pharmacogenetics: Economic considerations. / Hughes, D.; Hughes, D.A.; Pirmohamed, M.
Yn: Pharmacoeconomics, Cyfrol 25, Rhif 11, 01.01.2007, t. 899-902.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Hughes, D, Hughes, DA & Pirmohamed, M 2007, 'Warfarin pharmacogenetics: Economic considerations.', Pharmacoeconomics, cyfrol. 25, rhif 11, tt. 899-902.

APA

Hughes, D., Hughes, D. A., & Pirmohamed, M. (2007). Warfarin pharmacogenetics: Economic considerations. Pharmacoeconomics, 25(11), 899-902.

CBE

Hughes D, Hughes DA, Pirmohamed M. 2007. Warfarin pharmacogenetics: Economic considerations. Pharmacoeconomics. 25(11):899-902.

MLA

Hughes, D., D.A. Hughes a M. Pirmohamed. "Warfarin pharmacogenetics: Economic considerations.". Pharmacoeconomics. 2007, 25(11). 899-902.

VancouverVancouver

Hughes D, Hughes DA, Pirmohamed M. Warfarin pharmacogenetics: Economic considerations. Pharmacoeconomics. 2007 Ion 1;25(11):899-902.

Author

Hughes, D. ; Hughes, D.A. ; Pirmohamed, M. / Warfarin pharmacogenetics: Economic considerations. Yn: Pharmacoeconomics. 2007 ; Cyfrol 25, Rhif 11. tt. 899-902.

RIS

TY - JOUR

T1 - Warfarin pharmacogenetics: Economic considerations.

AU - Hughes, D.

AU - Hughes, D.A.

AU - Pirmohamed, M.

PY - 2007/1/1

Y1 - 2007/1/1

KW - PHARMACOLOGY & PHARMACY

M3 - Article

VL - 25

SP - 899

EP - 902

JO - Pharmacoeconomics

JF - Pharmacoeconomics

SN - 1170-7690

IS - 11

ER -